Latest Articles

Publication Date
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis - Frontiers

Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis Frontiers

Published: June 3, 2025, 2:36 p.m.
A Strange Case of Fever: Hematopyometra As the Initial Presentation of Endometrial Adenocarcinoma - Cureus

A Strange Case of Fever: Hematopyometra As the Initial Presentation of Endometrial Adenocarcinoma Cureus

Published: May 17, 2025, 1:16 p.m.
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma - Frontiers

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma Frontiers

Published: May 12, 2025, 7:50 p.m.
Isolated Splenic Metastasis and Splenic Bed Recurrence From Endometrial Carcinoma: A Rare Case - Cureus

Isolated Splenic Metastasis and Splenic Bed Recurrence From Endometrial Carcinoma: A Rare Case Cureus

Published: May 6, 2025, 11:44 a.m.
Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis - Cureus

Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis Cureus

Published: April 30, 2025, 12:42 a.m.
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive

Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive

Published: April 28, 2025, 1:18 p.m.
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation - Frontiers

MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation Frontiers

Published: April 23, 2025, 2:47 p.m.
The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma - Frontiers

The value of multi-sequence magnetic resonance imaging and whole-tumor apparent diffusion coefficient histogram analysis in differentiating p53 abnormal from non-p53 abnormal endometrial carcinoma Frontiers

Published: April 15, 2025, 2:55 p.m.
Imaging of the Urachus.

The urachus is a remnant fibrous cord of the allantois and the ventral aspect of the cloaca that connects the urinary bladder to the anterior abdominal wall at the level …

Published: April 11, 2025, midnight
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today

Published: April 9, 2025, 3:15 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!